Logo

Gates Foundation Grants $13M to Lyndra Therapeutics for the Development of Once-Monthly Oral Contraceptive

Share this

Gates Foundation Grants $13M to Lyndra Therapeutics for the Development of Once-Monthly Oral Contraceptive

Shots:

  • The Gate Foundation has granted $13M to fund development program addressing the lack of global family planning options. The development of once-monthly oral contraceptive will provide women with a discreet- non-invasive option to support their family planning
  • Additionally- the Gates Foundation awarded a grant to Lyndra to develop long-acting malaria therapy and will provide funds for P-II clinical study- expansion of its P-I pipeline and manufacturing scale-up
  • Lyndra’s once-monthly oral combination therapy delivers sustained- the steady-state release of estrogen and progestin improving medication adherence and health outcomes while reducing the burdens on individuals and their caregivers

Click here to­ read full press release/ article | Ref: Lyndra Therapeutics | Image: The Pharma Letter


Senior Editor

This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions